EUVIMEDEUVIMED entdecken
Crossref

75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects

B.S. Chandrashekar, Sushil Tahiliani, Abhishek De, Dyotona Sen

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB10

DOI: 10.1016/j.jaad.2026.04.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von B.S. Chandrashekar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chandrashekar, B., Tahiliani, S., De, A., & Sen, D. (2026). 75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects. Journal of the American Academy of Dermatology, 95(1), AB10. https://doi.org/10.1016/j.jaad.2026.04.059

Vancouver

Chandrashekar B, Tahiliani S, De A, Sen D. 75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects. Journal of the American Academy of Dermatology. 2026;95(1):AB10. doi:10.1016/j.jaad.2026.04.059

BibTeX
@article{Chandrashekar2026,
  author = {Chandrashekar, B.S. and Tahiliani, Sushil and De, Abhishek and Sen, Dyotona},
  title = {75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB10},
  doi = {10.1016/j.jaad.2026.04.059}
}
Kostenlos starten →